# Efficacy and Safety of Liposomal Bupivacaine Using Periarticular Injection in Total Knee Arthroplasty

> **NCT06557018** · PHASE4 · RECRUITING · sponsor: **Dezhou Hospital Qilu Hospital of Shandong University** · enrollment: 60 (estimated)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** liposomal bupivacaine
- **DRUG:** traditional peri-articular injection

## Key facts

- **NCT ID:** NCT06557018
- **Lead sponsor:** Dezhou Hospital Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-25
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-09-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06557018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06557018, "Efficacy and Safety of Liposomal Bupivacaine Using Periarticular Injection in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06557018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*